ストックスクリーナーアプリを入手
0.1546
0.32%
-0.0005
アフターアワーズ：
.15
-0.0046
-2.98%
前日終値:
$0.1551
開ける：
$0.1585
24時間の取引高:
4.14M
Relative Volume:
0.44
時価総額：
$1.48M
収益：
-
当期純損益:
$-6.78M
株価収益率:
-0.00362
EPS:
-42.6996
ネットキャッシュフロー:
$-4.67M
1週間 パフォーマンス:
-15.57%
1か月 パフォーマンス:
-84.38%
6か月 パフォーマンス:
-83.91%
1年 パフォーマンス:
-87.92%
1日の値動き範囲:
$0.1478
$0.1585
1週間の範囲:
$0.1404
$0.2025
52週間の値動き範囲:
$0.1404
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
CMND を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
0.1546 | 5.13M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clearmind Medicine Inc (CMND) 最新ニュース
Clearmind Medicine schedules annual and special shareholder meeting for December - Investing.com
Why Did Clearmind Medicine Shares Jump 7% In Pre-Market Trading? - Benzinga
Tel Aviv Sourasky Medical Center enrolls first patient in Clearmind’s AUD trial - Investing.com Nigeria
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial - The Manila Times
Clearmind Medicine stock rises after positive safety data in alcohol disorder trial - Investing.com Nigeria
Clearmind reports positive interim safety data for alcohol disorder drug - Investing.com
Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review - The Manila Times
Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of ... - Enidnews.com
Adversity is less terrifying than hope: Clearmind Medicine Inc (CMND) - Setenews
Clearmind Medicine Inc Stock Analysis and ForecastVolatility Index Analysis & Free Trend Following Techniques - earlytimes.in
SciSparc, Clearmind Medicine file Israeli patent application for depression - MSN
Clearmind Medicine initiates Phase I/IIa clinical trial for CMND-100 - MSN
Clearmind Medicine Inc. (CMND) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Clearmind begins phase I/IIa trial for alcohol disorder drug at Hadassah - Investing.com Nigeria
What macro factors could drive Clearmind Medicine Inc. (CWY0) stock higherAnalyst Downgrade & Consistent Profit Trade Alerts - newser.com
Can Clearmind Medicine Inc. (CWY0) stock survive global slowdownSell Signal & High Return Trade Opportunity Guides - newser.com
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression - The Manila Times
SciSparc: Neurothera Labs Announces Israeli Patent - GlobeNewswire
Clearmind begins phase I/IIa trial for alcohol disorder drug at Hadassah By Investing.com - Investing.com South Africa
Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site - The Manila Times
Clearmind Medicine files Israeli patent for depression treatment - MSN
Will Clearmind Medicine Inc. stock reach all time highs in 2025July 2025 EndofMonth & Real-Time Volume Triggers - newser.com
Clearmind Medicine announces results from Phase I/IIa trial of CMND-100 - MSN
Will Clearmind Medicine Inc. stock keep outperforming rivals2025 Technical Overview & Accurate Intraday Trade Tips - newser.com
Can Clearmind Medicine Inc. (CWY0) stock double in coming yearsMarket Trend Review & Fast Exit Strategy with Risk Control - newser.com
Why Clearmind Medicine Inc. stock could benefit from AI revolutionMarket Growth Review & Weekly Return Optimization Alerts - newser.com
Strategies to average down on Clearmind Medicine Inc.Analyst Upgrade & Breakout Confirmation Alerts - newser.com
How Clearmind Medicine Inc. stock performs after earningsJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
How sentiment analysis helps forecast Clearmind Medicine Inc.Portfolio Profit Report & Safe Capital Growth Tips - newser.com
Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression - Yahoo Finance
Neurothera Labs and Clearmind Medicine File Patent for Innovative Depression Treatment - TipRanks
Why Clearmind Medicine Inc. (CWY0) stock gets analyst attentionWeekly Market Report & Daily Chart Pattern Signals - newser.com
Clearmind Medicine Inc (CMND) 財務データ
収益
当期純利益
現金流量
EPS
0.45%
1.13%
大文字化:
|
ボリューム (24 時間):